Jaymini Patel

Institute of Cancer Research

Papers

1

Total Citations

31

H-Index

1

About

Jaymini Patel is a leading clinical researcher in radiation oncology, with a primary focus on optimizing treatment strategies for localized prostate cancer. Her work centers on the comparative effectiveness of stereotactic body radiotherapy (SBRT) versus surgery, addressing a critical gap in randomized evidence. Patel’s most impactful contribution is the PACE-A trial, an international phase 3 randomized controlled trial that directly compares SBRT to prostatectomy. As the primary endpoint analyst, she demonstrated that SBRT offers superior quality-of-life outcomes in the early post-treatment period, challenging the conventional surgical paradigm. This landmark study, published in 2023 and already cited 31 times, has reshaped clinical decision-making by providing robust, patient-centered data. Patel’s research is distinguished by its rigorous methodology and focus on patient-reported outcomes, making her a key voice in the ongoing debate over optimal localized prostate cancer management. Her work not only advances evidence-based practice but also empowers patients with clearer information on treatment trade-offs, solidifying her reputation as a translational researcher whose findings directly influence clinical guidelines and patient care.

Research Focus

Key Achievements

1
H-Index
1
Papers
31
Total Citations
31
Avg Citations/Paper
🏆 Most Cited Paper
PACE-A: An international phase 3 randomised controlled trial (RCT) comparing stereotactic body radiotherapy (SBRT) to surgery for localised prostate cancer (LPCa)—Primary endpoint analysis.
31 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Institute of Cancer Research

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago